LOGO INSERM 1

11ème Workshop International ANRS MIE HBV CURE
Programme - 3 juillet 2024 Lyon, France

Functional Cure, Clinical Aspects

The new treatment guidelines for CHB and CHD: are we moving towards functional cure?
Markus Cornberg, Hannovre
Impact of HBV DNA integration on functional cure
Patrick Kennedy, London

Impact Of HBV DNA Integration On Functional Cure​

Novel insight in the regulation of cccDNA transcription
Barbara Testoni, Lyon
Mechanism of exhaustion of B and T cells and path for functional recovery
Robert Thimme, Freiburg

Flash Communications / Young Investigators​

Young investigators, Role of H2A.Z histone variants on HBV replication
Basile Jay, Montpellier
Understanding the initial phase of HBV assembly: L-induced recruitment of empty and full capsids  in late-endocytic-related domains
Carla Vanessa Sarabia Vega, Tours
Development of FXR agonists as antivirals against hepatitis viruses
Romain Barnault, Lyon
Capsid assembly modulators against HBV: old molecules with new mechanisms of action
Valerio Taverniti, Strasbourg

Patient perspectives on HBV cure

Milan Mishkovikj (ELPA) & SOS Hépatites

HDV session​

HDV origin in Homo Sapiens
Frederic Le Gal, Bobigny
Intrahepatic decay of HDV during Bulevirtide therapy
Miroslava Subic Levrero, Lyon
Insight on HDV – host cell interactions for drug discovery
Eloi Verrier, Strasbourg
Mode of action of Nucleic Acid Polymers in HDV infection
Massimo Levrero, Lyon

Drug development​

Results of clinical trials of novel cure strategies
Marc Bourlière, Marseille
CAM inhibitors as backbone treatments for functional cure
Raymond Schinazi, Atlanta
Immunological correlates of functional cure
Georg Lauer, Boston

Soutenu par

LOGO INSERM

Mentions légales

11ème Workshop International ANRS MIE HBV CURE